UK move prompts push for Kadcyla in NZ

BCAC is pushing for breakthrough breast cancer drug, Kadcyla, to be publicly funded in New Zealand after a “monumental u-turn” in the UK which has seen the drug funded there.

Debunking the myth of lymphoedema risk

The risk of developing breast cancer-related lymphoedema is associated with a range of factors, not just axillary (armpit) node surgery as is widely believed, a new study reveals.

Women with breast cancer eligible for free ‘flu vaccination

If you have breast cancer you are eligible for a free influenza vaccination and now is the best time to be immunised before the winter ‘flu season arrives.

The annual immunisation is recommended for people with ongoing medical conditions, who are at a higher risk of developing serious complications from influenza, such as pneumonia.